Cargando…
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Amikacin liposome inhalation suspension (ALIS) [Arikayce(®) Liposomal (EU); Arikayce(®) (USA)], a liposomal suspension of the aminoglycoside amikacin (590 mg) for nebulization via the Lamira(®) Nebulizer System, is available as add-on therapy for treatment-refractory Mycobacterium avium complex (MAC...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053653/ https://www.ncbi.nlm.nih.gov/pubmed/33723805 http://dx.doi.org/10.1007/s40261-021-01010-z |